NCT01443702

Use of Lapis Judaicus to Dissolve Kidney Stones

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Shiraz University of Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The investigators will investigate the safety and effectiveness of an Iranian traditional medicine regarding its ability to dissolve existing kidney stones. Calcium stone formers will be recruited for a 12 week trial. Each subject will receive Lapis judaicus or placebo in random order. End points are changes in urinary chemistries and stone burden by Ultra sonography / CT scan. It will be used in proven calcium stone forming adults who are not pregnant. This phase is a double blind, randomized, placebo controlled Entry, first and 12 week 24 hour urine supersaturations, pH and sodium determinations will be collected. Entry and final stone quantification Ultra sonography / CT scan will be performed. End points will be changes in urine chemistry/supersaturation and stone quantitative stone volume.

Conditions

• Kidney Calculi

Interventions

Type	Name	Description
DRUG	Lapis Judaicus	2 g capsule per day.
DRUG	Placebo	2 g capsule per day.

Timeline

• Start date: 2011-01-01
• Primary completion: 2011-12-01
• First posted: 2011-09-30
• Last updated: 2013-12-02

Locations

1 site across 1 country: Iran